High-dose liposomal daunorubicin and hig
โ
Jorge Cortes; Elihu Estey; Susan O'Brien; Francis Giles; Yu Shen; Charles Koller
๐
Article
๐
2001
๐
John Wiley and Sons
๐
English
โ 89 KB
๐ 2 views
## Background: Liposomal encapsulation of daunorubicin (daunoxome, dnx; nexstar pharmaceutical, boulder, co) changes the pharmacology profile to increase delivery to tumor sites and decrease toxicity. the authors investigated the effect of daunorubicin in combination with ara-c in patients with ref